A carregar...
Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal Cancers
Immune checkpoint inhibition has transformed cancer treatment. For gastroesophageal cancer, this class of drugs have demonstrated durable responses and survival benefit in a subgroup of patients, resulting in regulatory approval. However, several recent randomized phase III studies in gastroesophage...
Na minha lista:
| Publicado no: | Front Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7243739/ https://ncbi.nlm.nih.gov/pubmed/32500029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00763 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|